Account-creators
1,040
edits
Jensflorian (talk | contribs) (+general) |
Jensflorian (talk | contribs) m (history) |
||
Line 7: | Line 7: | ||
* duplication. | * duplication. | ||
* inversion. | * inversion. | ||
First fusion was described as BCR-ABL1 fusion in [[CML]]. Subsequently [[Imatinib]] was the first inhibitor targeting CML with BCR-ABL1 fusion. |